41 completed, 1 terminated, 1 unknown. 43 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 43 | Completed 41, Terminated 1, Unknown 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow ciclesonide: new trials by email Literature Review of ciclesonide trials Research Report on ciclesonide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V Niclosamide, Placebo, Ciclesonide - Covid19 | Phase 2 / Phase 3 | Completed | Cambridge University Hospitals NHS Foundation Trust | 2240 | 2021-02-19 | 2025-06-20 |
| Inhaled Ciclesonide for Outpatients With COVID19 Normal Saline intranasal and placebo inhaler, Ciclesonide, Ciclesonide nasal - COVID 19 | Phase 2 / Phase 3 | Terminated | McGill University Health Centre/Research Institute of the McGill University Health Centre | 215 | 2020-09-15 | 2022-06-10 |
| Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation Vitamins, Telmisartan, Ciclesonide - Corona Virus Infection, Sars-CoV2 | Phase 2 / Phase 3 | Completed | University Hospital, Bordeaux | 412 | 2020-07-29 | 2026-05-12 |
| A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients Ciclesonide, Placebo - COVID-19 | Phase 3 | Completed | Covis Pharma S.à.r.l. | 400 | 2020-06-08 | 2023-02-09 |
| Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis Ciclesonide, Fluticasone - Chronic Rhinosinustis With Polyps | Phase 3 | Unknown | Tehran University of Medical Sciences | 32 | 2016-01-01 | 2016-01-28 |
| Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia Ciclesonide, Ciclesonide Placebo - Seasonal Allergic Rhinitis | Phase 3 | Completed | AstraZeneca | 80 | 2014-08-01 | 2017-02-02 |
| Effect of High Dose Ciclesonide on Asthma Control Ciclesonide - Bronchial Asthma | Phase 3 | Completed | AstraZeneca | 520 | 2011-11-01 | 2017-02-10 |
| Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray ciclesonide, mometasone - Perennial Allergic Rhinitis | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 327 | 2011-07-01 | 2013-04-30 |
| Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma Vitamin D3, Ciclesonide - Asthma | Phase 3 | Completed | Milton S. Hershey Medical Center | 408 | 2011-04-01 | 2014-08-13 |
| Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis Ciclesonide HFA Nasal Aerosol 320 mcg, Ciclesonide HFA Nasal Aerosol 160 mcg, HFA Nasal Aerosol placebo - Perennial Allergic Rhinitis | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 310 | 2010-01-01 | 2012-07-19 |
| Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis 80 mcg Ciclesonide, 160 mcg Ciclesonide, Placebo - Seasonal Allergic Rhinitis | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 707 | 2008-11-01 | 2016-04-08 |
| A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma Ciclesonide, Placebo, Salbutamol - Asthma | Phase 3 | Completed | AstraZeneca | 1080 | 2006-09-01 | 2017-02-01 |
| Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma. Ciclesonide, Placebo - Asthma | Phase 3 | Completed | AstraZeneca | 528 | 2006-09-01 | 2017-02-01 |
| Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101) Ciclesonide, Fluticasone - Asthma | Phase 3 | Completed | AstraZeneca | 37 | 2006-05-01 | 2017-02-01 |
| Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101) Ciclesonide - Asthma | Phase 3 | Completed | AstraZeneca | 101 | 2006-02-01 | 2016-12-05 |
| Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207) Ciclesonide, Placebo - Asthma | Phase 3 | Completed | AstraZeneca | 1000 | 2005-11-01 | 2016-12-08 |
| Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416) Ciclesonide - Hay Fever, Perennial Allergic Rhinitis | Phase 3 | Completed | AstraZeneca | 102 | 2005-11-01 | 2016-11-30 |
| Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid. Ciclesonide (XRP1526) - Asthma | Phase 3 | Completed | Sanofi | 708 | 2005-09-01 | 2009-04-08 |
| Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208) Ciclesonide - Asthma | Phase 3 | Completed | AstraZeneca | 28 | 2005-09-01 | 2016-12-01 |
| Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145) Ciclesonide - Asthma | Phase 3 | Completed | AstraZeneca | 450 | 2005-09-01 | 2016-11-30 |
Showing 20 of 43. Sign in to see all of them.
Asthma (25) · Rhinitis, Allergic, Seasonal (9) · Rhinitis, Allergic, Perennial (8) · Rhinitis, Allergic (4) · COVID-19 (3) · Hypersensitivity (3) · Respiratory Hypersensitivity (2) · Coronavirus Infections (1) · Disease (1) · Glomerulonephritis (1) · Lupus Erythematosus, Systemic (1) · Nasal Polyps (1) · Neoplasms (1) · Respiratory Tract Diseases (1) · Vasculitis (1)
AstraZeneca (29) · Sanofi (4) · Sumitomo Pharma America, Inc. (3) · Cambridge University Hospitals NHS Foundation Trust (1) · Covis Pharma S.à.r.l. (1) · Hamilton Health Sciences Corporation (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Milton S. Hershey Medical Center (1) · Tehran University of Medical Sciences (1) · University Hospital, Bordeaux (1)
United States (15) · Canada (9) · Hungary (7) · Poland (7) · South Africa (7) · Germany (6) · Russia (5) · Brazil (4) · France (4) · Netherlands (4) · Spain (4) · India (3) · United Kingdom (3) · Argentina (2) · Belgium (2)
Anne Fitzpatrick, MD (1) · Christine Sorkness, MD (1) · Craig LaForce, MD (1) · David T. Mauger, PhD (1) · Elizabeth Bade, MD (1) · Elliot Israel, MD (1) · Homer Boushey, MD (1) · James Chmiel, MD (1) · James Moy, MD (1) · Jerry Krishnan, MD (1) · Julian Solway, MD (1)
PMID 18070931, PMID 18071011, PMID 18287130, PMID 19085579, PMID 19549431, PMID 19549432, PMID 20595155, PMID 20619624, PMID 21088114, PMID 21130386, PMID 21839625, PMID 24169063, PMID 24838406, PMID 26971692, PMID 32738928, PMID 33050924, PMID 33388170, PMID 34473343, PMID 34728476, PMID 34807241, PMID 36915199, PMID 38454482, PMID 39934669, PMID 41656183
U10HL098115 (1)